MTI reiterates Singapore's focus on biomedical sciences
This is to address the increased global demand for healthcare products.
Minister for Trade and Industry Gan Kim Yong affirmed the country’s focus on biomedical sciences during his speech at the Takeda groundbreaking ceremony.
In his speech, Yong talks about the heavy investment by the government in research and development.
“We have manufacturing facilities across a wide range of products, including bulk active pharmaceutical ingredients, bulk biologics, drug products, and nutritionals, headquartered here in Singapore. The sector invests heavily in research and development and has a strong focus on innovation, supported by a growing talent pool. This enables the sector to create a diverse range of job opportunities for Singaporeans.”
According to Yong, this is due to the increased global demand for healthcare products due to the COVID-19 pandemic. Companies such as Takeda also invested in Singapore to leverage the resources available in Singapore.
“I am also glad that we have developed strong public-private initiatives over the years, such as the Biopharmaceutical Manufacturers’ Advisory Council (BMAC), which includes EDB and JTC, as well as 16 top biopharmaceutical companies in Singapore, including Takeda," Yong said.
"BMAC brings together the public and private sector to exchange views and collaborate on emerging trends, opportunities, and challenges in the industry. One of the key focus areas for BMAC is sustainability. BMAC companies work together to develop best practices and share knowledge on innovative technologies to minimise waste, reduce their carbon footprint, and contribute to a greener future for Singapore."
Sustainability was also one of the main topics of Yang, as the Singapore Green Plan 2030 was unveiled earlier throughout the year.
“Earlier this year, the government unveiled the Singapore Green Plan 2030, which charts out Singapore’s path towards a more sustainable future. This includes greening 80% of our buildings through smart and sustainable building solutions. We are encouraged by Takeda’s decision to site its first carbon zero building in Singapore. This illustrates the company’s commitment to combat climate change and make its operations environmentally sustainable, complementing our efforts in greening Singapore’s industrial estates.”